The Form 4 filing, a report of insider stock activity, was filed on Nov. 9, 2026. It lists Nov. 5, 2026, as the sale date for Andre Schulten, Procter & Gamble's chief financial officer.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-05 |
| Date of Latest Transaction | 2026-11-05 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 30,677 |
| Price | $169.00 |
| Total Transaction Value | $5,184,413.00 |
| Insider | |
| Ticker Symbol | PG |
| Company | PROCTER & GAMBLE Co |
| Insider Name | Schulten Andre |
| Insider Title | Chief Financial Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 65,618.01 |
| Position Size Change | 31.86% |
| Filing | |
| Filing Date | 2026-11-09 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Procter & Gamble (PG) shares under transaction code S. The transaction details suggest a link to an exercise or conversion in the same filing. Those terms describe using a right to receive shares or exchanging another investment for shares.
What was the average price of the transaction?
The reported average sale price was $169.00 per share for the 30,677 shares sold.
How did this transaction affect the insider's holdings?
Andre Schulten sold 30,677 shares and reported 65,618.01 shares owned afterward. The shares sold made up 31.86% of his reported shares owned before the sale.
What's the total transaction value?
The total transaction value was $5,184,413.00. This amount covers the one reported sale on Nov. 5, 2026.
Are there any special circumstances around this transaction?
The link is based on a matching share count: an M-coded exercise or conversion in the same filing also involved 30,677 shares. Footnote text and details for that related transaction were not available.
The share count alone does not show whether the dates, share types, or accounts matched. It also does not confirm that the exact shares received were sold or that the sale paid taxes.
For research purposes only; not investment advice.